Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The aim of the NHS CSP is to reduce the incidence of, and mortality from, cervical cancer by delivering a systematic quality assured population-based screening programme for eligible people.
The aim of the Service is to support the delivery of the NHS CSP by testing samples and making direct referrals to colposcopy.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| The Royal Wolverhampton NHS Trust | - | £20,050,605 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £20,050,605 initial term | 1 single bid — no competition | The Royal Wolverhampton NHS Trust | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using Direct Award Process C.
Contract Start Date: 01 July 2026
Contract End Date: 31 March 2029
Contract Value: £20,050,605
Details of the individuals/group making the award decision:
Senior Commissioning Manager - NHS England
Contracts Manager - NHS England
Senior Commissioning Manager - NHS England
Midlands SGG (Screening Governance Group) and RCG (Regional Commissioning Group)
The existing provider is satisfying the existing contract and will likely satisfy the proposed new contract. The provider has been assessed and passed against the relevant 5 key criteria and mandatory requirements.
There were no conflicts of interests identified.